BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
57.24
+0.75 (1.33%)
At close: Apr 1, 2026, 4:00 PM EDT
57.27
+0.03 (0.05%)
After-hours: Apr 1, 2026, 6:21 PM EDT

BioMarin Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11,00911,39812,53918,18519,27516,249
Market Cap Growth
-19.32%-9.10%-31.05%-5.66%18.63%1.96%
Enterprise Value
10,09110,43411,99618,19819,06716,314
Last Close Price
57.2459.4365.7396.42103.4988.35
PE Ratio
31.7233.0229.74110.83137.99-252.43
Forward PE
10.7212.3717.8638.9839.0085.79
PEG Ratio
0.420.650.721.070.862.66
PS Ratio
3.423.544.397.529.208.80
PB Ratio
1.811.872.223.674.193.81
P/TBV Ratio
1.831.932.293.734.253.79
P/FCF Ratio
15.1915.7225.72290.64350.8277.76
P/OCF Ratio
13.3013.7721.89114.18109.5853.36
EV/Sales Ratio
3.133.244.207.529.108.84
EV/EBITDA Ratio
13.9621.3420.6662.7272.51634.83
EV/EBIT Ratio
15.5125.4824.7797.96118.45-198.13
EV/FCF Ratio
13.9214.3924.61290.85347.0278.07
Debt / Equity Ratio
0.100.100.110.220.240.25
Debt / EBITDA Ratio
1.221.221.023.754.1241.99
Debt / FCF Ratio
0.820.821.2217.3719.715.16
Net Debt / Equity Ratio
-0.16-0.16-0.100.00-0.040.02
Net Debt / EBITDA Ratio
-1.97-1.97-0.930.05-0.792.54
Net Debt / FCF Ratio
-1.33-1.33-1.110.21-3.790.31
Asset Turnover
0.440.440.410.370.340.31
Inventory Turnover
0.570.570.500.530.600.64
Quick Ratio
3.253.252.961.452.982.54
Current Ratio
5.215.215.332.514.674.16
Return on Equity (ROE)
5.94%5.94%8.05%3.51%3.19%-1.53%
Return on Assets (ROA)
4.06%4.06%5.52%2.50%2.46%-1.18%
Return on Invested Capital (ROIC)
5.63%5.63%7.39%3.44%3.38%-1.59%
Return on Capital Employed (ROCE)
6.20%6.20%8.04%3.24%2.86%-1.52%
Earnings Yield
3.17%3.03%3.36%0.90%0.72%-0.40%
FCF Yield
6.59%6.36%3.89%0.34%0.29%1.29%
Buyback Yield / Dilution
-0.35%-0.35%-2.67%-1.39%-3.34%4.60%
Total Shareholder Return
-0.35%-0.35%-2.67%-1.39%-3.34%4.60%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q